Ameliorative efficacy of novel multi herbal formulation (AKSS16-LIV01) upon Haematological modulations induced by fixed dose combination of tramadol hydrochloride/paracetamol (THP)
Background: Tramadol hydrochloride/paracetamol (THP) a fixed dose combination (FDC) is widely spread analgesic used to treat moderate to moderately severe pain. Over dose or chronic use of this fixed dose combination produce serious adverse effects. An acute Tramadol hydrochloride/paracetamol (THP) overdose can lead to a fatal liver damage.
Objectives: There is a worldwide need to develop a safe and symptomatic medication which controls the different medical complications.
Materials and Methods: Healthy adult swiss albino mice were assigned to four groups of six mice each according to their weights. Group-I serve as control, Group-II received Multi herbal formulation (AKSS16 LIV01) 400 mg/kg/day, Group-III received Tramadol hydrochloride/paracetamol (THP) 1.68 g / 300ml water and Group-IV received THP along with AKSS16-LIV01 (400 mg/kg). Blood samples were collected from the retro orbital plexus of each animal to determine various blood parameters and liver transaminase. Results: Administration of THP showed decline body weight, food consumption and water intake in mice whereas treatment with Multi herbal formulation (AKSS16-LIV01) normalized the same as compared with untreated animals. Treatment with THP (Group-III) decline the packed cell volume (PCV), haempglobin (Hb), means cell volume (MCV), means cell hemoglobin (MCH) and greater the white blood cell (WBC) compared with control. Pre-treatment with AKSS16-LIV01 significantly (p<0.001) increased the PCV, Hb, MCH, MCH and decreased WBC count in experimental animals. On the other hand elevated liver transaminase enzymes i.e. AST and ALP by THP was restored with administration of Multi herbal formulation (AKSS16-LIV01).
Conclusion: Chronic administration of THP indicated adverse effects on haematologic parameters upon experimental animals. Simultaneous administration with newly developed multi herbal formulation (AKSS16-LIV01) was ameliorate these adverse effects and may be potent drug In the future which controls the blood related medical complications against the toxicants.
Keywords: Tramadol hydrochloride/paracetamol; Fixed dose combination; Multi herbal formulation; Hematologic parameters; Liver transaminase; Swiss albino mice
2. Mitrašinović-Brulić M, Kulovac A, Suljević D: Chronic Effects Of Tramadol Hydrochloride/Paracetamol Oral Administration On Haematological Parameters And Glucose Level In Wistar Rats.
3. Leppert W: Tramadol As An Analgesic For Mild To Moderate Cancer Pain. Pharmacological Reports 2009; 61(6):978-992.
4. Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek M, Akgül Ö, Kozak O, Kurt E, Aypar U: Spinal 5-Ht7 Receptors Play An Important Role In The Antinociceptive And Antihyperalgesic Effects Of Tramadol And Its Metabolite, O-Desmethyltramadol, Via Activation Of Descending Serotonergic Pathways. Anesthesiology: The Journal Of The American Society Of Anesthesiologists 2010; 112(3):696-710.
5. Kaneko K, Umehara M, Homan T, Okamoto K, Oka M, Oyama T: The Analgesic Effect Of Tramadol In Animal Models Of Neuropathic Pain And Fibromyalgia. Neuroscience Letters 2014; 562:28-33.
6. Aldiwan Ma, Alzobidy Amh, Younis Ma: The Effect Of Tramadol On Some Blood And Biochemical Parameters Of Male Rats (Rattus Norvegicus). Baghdad Science Journal 2015; 12(3):496-502.
7. Clack L, Kadlec L, Wendicke A: Producing Better Data To Help Combat Opioid Dependence. Journal Of Ahima 1918:39.
8. Chandanwale As, Sundar S, Latchoumibady K, Biswas S, Gabhane M, Naik M, Patel K: Efficacy And Safety Profile Of Combination Of Tramadol-Diclofenac Versus Tramadol-Paracetamol In Patients With Acute Musculoskeletal Conditions, Postoperative Pain, And Acute Flare Of Osteoarthritis And Rheumatoid Arthritis: A Phase Iii, 5-Day Open-Label Study. Journal Of Pain Research 2014; 7:455.
9. Raffa Rb, Clark-Vetri R, Tallarida Rj, Wertheimer Ai: Combination Strategies For Pain Management. Expert Opinion On Pharmacotherapy 2003; 4(10):1697-1708.
10. Hasan Sz, Misra V, Singh S, Arora G, Sharma S, Sharma S: Current Status Of Herbal Drugs And Their Future Perspectives. In: Biol Forum Int J: 2009. Citeseer: 12-17.
11. Srivastava S, Lal Vk, Pant Kk: Polyherbal Formulations Based On Indian Medicinal Plants As Antidiabetic Phytotherapeutics. Phytopharmacology 2012; 2(1):1-15.
12. Thyagarajan S, Jayaram S, Gopalakrishnan V, Hari R, Jeyakumar P, Sripathi M: Herbal Medicines For Liver Diseases In India. Journal Of Gastroenterology And Hepatology 2002; 17:S370-S376.
13. Darbar S, Saha S, Pramanik K, Chattopadhyay A: Preliminary Assessment Of Acute And 28-Day Repeated Dose Oral Toxicity Of A Newly Developed Herbal Mixture On Experimental Animal. Indian Journal Of Pharmaceutical Education And Research 2020; 54(1):135-142.
14. Adhikari A, Darbar S, Chatterjee T, Das M, Polley N, Bhattacharyya M, Bhattacharya S, Pal D, Pal Sk: Spectroscopic Studies On Dual Role Of Natural Flavonoids In Detoxification Of Lead Poisoning: Bench-To-Bedside Preclinical Trial. Acs Omega 2018; 3(11):15975-15987.
15. Thornton J, Losowsky M: Severe Thrombocytopenia After Paracetamol Overdose. Gut 1990; 31(10):1159.
16. Waris N, Kausar R, Waris N, Naz F, Raza A: Effect Of Extra Panadol On Blood And Behavior Of Rats. J Bioanal Biomed 2017; 9(4):206-211.
17. Cascio Mj, Deloughery Tg: Anemia: Evaluation And Diagnostic Tests. Medical Clinics 2017; 101(2):263-284.
18. Tung H-T, Cook F, Wyatt R, Hamilton P: The Anemia Caused By Aflatoxin. Poultry Science 1975; 54(6):1962-1969.
19. Thapa B, Walia A: Liver Function Tests And Their Interpretation. The Indian Journal Of Pediatrics 2007; 74(7):663-671.
20. Gonzalez-Casas R, Jones Ea, Moreno-Otero R: Spectrum Of Anemia Associated With Chronic Liver Disease. World Journal Of Gastroenterology: Wjg 2009; 15(37):4653.
21. Gkamprela E, Deutsch M, Pectasides D: Iron Deficiency Anemia In Chronic Liver Disease: Etiopathogenesis, Diagnosis And Treatment. Annals Of Gastroenterology 2017; 30(4):405.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).